Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nir Peled

Showing results (41-50 of 219) with videos related to

Pageof 22
Sort By:
Journal of Clinical Medicine|June 26, 2026
Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center StudyEinav Koren, Adar Yaacov, Jamal Zidan, et al.
Diseases of the Colon and Rectum|October 27, 2007
Fecal calprotectin as a predictor of abnormal colonic histologyAriella Bar-Gil Shitrit, Dan Braverman, Halina Stankiewics, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 29, 2011
Classification of lung cancer histology by gold nanoparticle sensorsOrna Barash, Nir Peled, Ulrike Tisch, et al.
Clinical Lung Cancer|July 16, 2019
Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer ScreeningYaakov Tolwin, Roni Gillis, Inbar Nardi Agmon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
Effective crizotinib schedule for brain metastases in ALK rearrangement metastatic non-small-cell lung cancerNir Peled, Leor Zach, Ori Liran, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Nivolumab Induced Hepatocanalicular Cholestasis and Liver Rejection in a Patient With Lung Cancer and Liver TransplantMarius Braun, Vered Fuchs, Waleed Kian, et al.
Expert Review of Molecular Diagnostics|September 17, 2010
Early detection and screening of lung cancerCeline Mascaux, Nir Peled, Kavita Garg, et al.
Journal of Pain and Symptom Management|December 7, 2024
Identifying Factors Associated with Disparities in Accessing an Integrative Oncology ProgramNoah Samuels, Orit Gressel-Raz, Nir Peled, et al.
Harefuah|December 4, 2017
[THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER]Anna Belilovski Rozenblum, Maya Ilouze, Elizabeth Dudnik, et al.
Lung Cancer (Amsterdam, Netherlands)|January 23, 2010
New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancerRobert C Doebele, Ana B Oton, Nir Peled, et al.
Pageof 22

Showing results (41-50 of 219) with videos related to

Sort By:
Pageof 22
Journal of Clinical Medicine|June 26, 2026
Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center StudyEinav Koren, Adar Yaacov, Jamal Zidan, et al.
Diseases of the Colon and Rectum|October 27, 2007
Fecal calprotectin as a predictor of abnormal colonic histologyAriella Bar-Gil Shitrit, Dan Braverman, Halina Stankiewics, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|October 29, 2011
Classification of lung cancer histology by gold nanoparticle sensorsOrna Barash, Nir Peled, Ulrike Tisch, et al.
Clinical Lung Cancer|July 16, 2019
Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer ScreeningYaakov Tolwin, Roni Gillis, Inbar Nardi Agmon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
Effective crizotinib schedule for brain metastases in ALK rearrangement metastatic non-small-cell lung cancerNir Peled, Leor Zach, Ori Liran, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2020
Nivolumab Induced Hepatocanalicular Cholestasis and Liver Rejection in a Patient With Lung Cancer and Liver TransplantMarius Braun, Vered Fuchs, Waleed Kian, et al.
Expert Review of Molecular Diagnostics|September 17, 2010
Early detection and screening of lung cancerCeline Mascaux, Nir Peled, Kavita Garg, et al.
Journal of Pain and Symptom Management|December 7, 2024
Identifying Factors Associated with Disparities in Accessing an Integrative Oncology ProgramNoah Samuels, Orit Gressel-Raz, Nir Peled, et al.
Harefuah|December 4, 2017
[THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER]Anna Belilovski Rozenblum, Maya Ilouze, Elizabeth Dudnik, et al.
Lung Cancer (Amsterdam, Netherlands)|January 23, 2010
New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancerRobert C Doebele, Ana B Oton, Nir Peled, et al.
Pageof 22